001     302283
005     20250731092439.0
024 7 _ |a 10.1038/s41684-025-01573-w
|2 doi
024 7 _ |a pmid:40571749
|2 pmid
024 7 _ |a 0093-7355
|2 ISSN
024 7 _ |a 1548-4475
|2 ISSN
024 7 _ |a altmetric:178400128
|2 altmetric
037 _ _ |a DKFZ-2025-01302
041 _ _ |a English
082 _ _ |a 630
100 1 _ |a Seib, Jessica
|0 P:(DE-HGF)0
|b 0
|e First author
245 _ _ |a Murine astrovirus infection course and antibody response in different mouse strains.
260 _ _ |a New York, NY
|c 2025
|b Nature Publ. Co.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1753946645_19396
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:W440#LA:W440# / 54, pages 178–187 (2025)
520 _ _ |a Monitoring the health of mice used in animal experiments constitutes an important instrument toward microbiological standardization, as infections can alter physiological parameters and immune reactions and may therefore have an essential impact on experimental outcome. In view of the high prevalence rates of murine astrovirus (MuAstV) infections in laboratory mouse facilities worldwide and the potential impact on research outcomes and reproducibility, there is a need to include MuAstV in the existing laboratory mice health monitoring programs. Here, to determine the sentinel strain and diagnostic method of choice, we aimed to assess the course of MuAstV infection and the resulting immune response in three immunocompetent mouse strains (Crl:CD1 (ICR), C57BL/6J and BALB/cOlaHsd) and one immunodeficient strain (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ) by analyzing blood, feces and tissue samples with MuAstV-specific polymerase chain reaction and serology. Depending on the mouse strain, the duration of infection and viral load differed significantly, as well as the rapidity and quantity of antibody production. Virus shedding in immunocompetent mice was limited to a maximum of 4 weeks, whereas immunodeficient mice shed virus for the entire duration of this study. A fast antibody response with high titers was found only in outbred CD1 mice. In C57BL/6J and BALB/c mice, however, seropositivity and high antibody levels were reached only after the second infection. These results not only improve our understanding of the infection characteristics of MuAstV, presumably the most prevalent virus in laboratory mice, but also help to set up a health monitoring routine giving meaningful and reliable results on the MuAstV infection status of laboratory mouse populations.
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Höfler, Daniela
|0 P:(DE-He78)3b05a05c74fcfafec06747c40ac929c0
|b 1
|u dkfz
700 1 _ |a Hornetz, Lena
|0 P:(DE-He78)03e697eff41037b4a1f95aa128292d6c
|b 2
|u dkfz
700 1 _ |a Ohl, Nicole
|0 P:(DE-He78)a34cae00e40416f4fdfb486dc0a2f5f0
|b 3
|u dkfz
700 1 _ |a Götz, Katrin
|0 P:(DE-He78)98179c914fa748a4060c13114dd4bfbb
|b 4
|u dkfz
700 1 _ |a Vogel, Klaus
|0 P:(DE-He78)9029e7d8e1a0081844702984bb4a06be
|b 5
|u dkfz
700 1 _ |a Butt, Julia
|0 P:(DE-He78)31d7c3e829be03400641f80b821ef728
|b 6
|u dkfz
700 1 _ |a Schmidt, Katja
|0 P:(DE-He78)4e5ebf211bad5a927f9a00c8e9c1d116
|b 7
|e Last author
|u dkfz
773 _ _ |a 10.1038/s41684-025-01573-w
|0 PERI:(DE-600)2822788-8
|p 178–187
|t Lab animal
|v 54
|y 2025
|x 0093-7355
909 C O |p VDB
|o oai:inrepo02.dkfz.de:302283
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)3b05a05c74fcfafec06747c40ac929c0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)03e697eff41037b4a1f95aa128292d6c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)a34cae00e40416f4fdfb486dc0a2f5f0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)98179c914fa748a4060c13114dd4bfbb
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)9029e7d8e1a0081844702984bb4a06be
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)31d7c3e829be03400641f80b821ef728
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)4e5ebf211bad5a927f9a00c8e9c1d116
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2025
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2024-12-14
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b LAB ANIMAL : 2022
|d 2024-12-14
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-14
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-14
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-14
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-14
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-14
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-14
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b LAB ANIMAL : 2022
|d 2024-12-14
920 2 _ |0 I:(DE-He78)W440-20160331
|k W440
|l Mikrobiologische Diagnostik
|x 0
920 1 _ |0 I:(DE-He78)W440-20160331
|k W440
|l Mikrobiologische Diagnostik
|x 0
920 1 _ |0 I:(DE-He78)D320-20160331
|k D320
|l Infektionen und Krebs-Epidemiologie
|x 1
920 1 _ |0 I:(DE-He78)W410-20160331
|k W410
|l Zentrum für Präklinische Forschung
|x 2
920 0 _ |0 I:(DE-He78)W440-20160331
|k W440
|l Mikrobiologische Diagnostik
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)W440-20160331
980 _ _ |a I:(DE-He78)D320-20160331
980 _ _ |a I:(DE-He78)W410-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21